Bausch Health

Laval, Canada Founded: 1960 • Age: 66 yrs Listed
Therapeutics for multiple diseases including dermatology and neurology are developed.

About Bausch Health

Bausch Health is a publicly listed company based in Laval (Canada) founded in 1960. Therapeutics for multiple diseases including dermatology and neurology are developed. The company has 20,700 employees. Bausch Health has completed 19 acquisitions, including Aton Pharma, Bausch & Lomb and DURECT. Its chief executive, as recorded, is Joseph Papa. Its website bauschhealth.com draws about 32 thousand monthly visits. Bausch Health offers products and services including Gastrointestinal Products, Dermatology Products, and Vision Care Products. Its focus areas include Life Sciences, Gastroenterology, Drugs and Diversified. Its legal entity is Bausch Health Companies Inc.

Company details

Founded in 1960 and headquartered in Laval, Canada, operations focus on the pharmaceutical sector where therapeutics are developed for conditions in dermatology, gastrointestinal disorders, eye health, neurology, and other areas. Products such as the lead candidate IDP-120 for acne treatment are manufactured. In 2023, annual revenues of 8.15 billion were recorded alongside a net loss of 0.36 billion.

  • Headquarters Laval, Canada
  • Employees 20,700
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website bauschhealth.com
  • Social LinkedIn X
  • Legal Name Bausch Health Companies Inc.
Operational Areas
Key Metrics
  • Annual Revenue
    $10.47 B (USD)
    8.79
    as on Dec 31, 2025
  • Net Profit
    $160.22 M (USD)
    as on Dec 31, 2025
  • EBITDA
    $3.46 B (USD)
    10.88
    as on Dec 31, 2025
  • Latest Funding Round
    $500M (USD), Debt – Conventional

    Mar 2019

  • Investors
  • Employee Count
    20,700
  • Investments & Acquisitions
    Aton Pharma

    & 18 more

Products & Services of Bausch Health

Bausch Health offers a comprehensive portfolio of products and services, including Gastrointestinal Products, Dermatology Products, and Vision Care Products.

Gastrointestinal Products
Pharmaceuticals

Treats gastrointestinal disorders with innovative medications.

Dermatology Products
Medical Devices

Provides solutions for skin conditions and aesthetic treatments.

Vision Care Products
Medical Devices

Offers eye care solutions including devices and pharmaceuticals.

Funding Insights of Bausch Health

  • Total Rounds 11
  • Last Round Debt – Conventional — $500M
  • First Round $14.53M

    (Mar 2002)

  • Investors Count 1

Latest 10 of 11 funding rounds of Bausch Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2019$500MDebt – Conventional––
–
Nov 2018$1.5BDebt – Conventional––
–
Jun 2018$5.79BDebt – Conventional––
–
Jun 2018Debt – Conventional––
–
Apr 2015$5.55BDebt – Conventional––
–
Mar 2015$10.09BDebt – Conventional––
–
Sep 2012$2.25BDebt – Conventional––
–
May 2009$365MDebt – Conventional––
–
Jun 2006Post-IPO––
Nov 2003$200MPost-IPO––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Bausch Health

Bausch Health has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ValueAct Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity investment firm based out of USA
valueact.comSan Francisco, United States
Premium access

Investor details for Bausch Health

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Bausch Health

552 people are tracked at Bausch Health (229 in leadership, 323 in team); the tracked headcount is 20,700.

NameRoleGroup
Joseph Papa
CEOLeadership
Pablo Marotta
Senior Director, Strategic Pricing – Us/globalLeadership
Richard Nagelberg
DirectorLeadership
Paul Schmidt
Director, Regional AccountsLeadership
Monika Beckmann
Executive Director, Project ManagementLeadership
Margie St.julien-Valbrun
DirectorLeadership
Kendra Grichuhin
Director Of Regulatory AffairsLeadership
Amy Cairns
General Manager, Bausch Health CanadaLeadership
Jessica Stow
Director, Commercial Litigation And Government InvestigationsLeadership
Ryszard Bukowski
Finance Director Of Manufacturing And Supply Chain - Emena RegionLeadership
Fernando Zarate
VP, Latin AmericaLeadership
Laimonas Ratkus
Finance Director CIS Countries/bulgaria/romania/greeceLeadership
Jean-Jacques Charhon
Executive Vice President & Chief Financial OfficerLeadership
Mario Enrique Perez Molina
Director Of Commercial OperationsLeadership
Dan Ewing
Sr. National Account DirectorLeadership
Alexander Bariso
Director Of Finance, R&dLeadership
Martin Roy
Director Of Information TechnologyLeadership
Jinsoo Lee
Director, Global Regulatory OperationsLeadership
Erik Miao
Director Human Resources,china - Solta MedicalLeadership
Nicole Rawnsley
Associate Director, MSL Field Strategy, Tactics And TrainingLeadership

532 more people are available in the full profile.

Premium access

Complete people profiles for Bausch Health

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Bausch Health

Bausch Health is a publicly listed company on the TSX with ticker symbol BHC in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date27 Jan 1999
  • Listed onNYSE: BHC
  • Listed entityBausch Health Companies Inc.
  • Exchange sectorHealth technology
  • ISINCA0717341071
  • Share price8.36 CAD (-3.24% on the day) · 2026-10-13
  • Market capitalisation3,126,561,037.00 CAD
  • Price to earnings6.7
  • EPS (diluted, trailing year)-4.06 CAD
  • Volume (last session)474,866

Financials of Bausch Health

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202514.34B CAD219.4M CAD4.74B CAD
202413.19B CAD-63.0M CAD4.28B CAD
202311.82B CAD-799.0M CAD3.87B CAD
202210.58B CAD-292.9M CAD3.63B CAD
202110.57B CAD-1.19B CAD3.92B CAD
Premium access

Detailed financial statements for Bausch Health

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Bausch Health

Bausch Health has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include Aton Pharma, Bausch & Lomb and DURECT.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Developer of therapeutics for chronic diseases and pain
durect.comCupertino, United States1998Jul 2025••••
Provider of an augmented reality marketing platform
paragonar.comColombo, Sri Lanka2015Feb 2017••••
Manufacturer of OTC drugs
euvipharm.com2005Jan 2017$7.44M
Drugs for hypoactive sexual desire disorder in women are developed.
sproutpharmaceuticals.comRaleigh, United States2011Aug 2015$1B
Provider of eye care products like corneal reshaping products, contact lenses & others
paragonvision.comGilbert, United States1976May 2015••••
Specialty pharmaceutical company focusing on prevention and treatment of gastrointestinal (GI) disorders.
salix.comBridgewater, United States1989Feb 2015$15.8B
Dermatology products are developed, manufactured, and marketed by PreCision Dermatology.
precisionderm.comCumberland, United States2010Feb 2014$475M
Energy-based aesthetic medical devices are designed and marketed.
solta.comHayward, United States1995Dec 2013$250M
Pharmaceutical ingredients and formulations are manufactured under contract.
euvipharm.com.vnLong An, Vietnam2005Jun 2013••••
Ophthalmic pharmaceuticals and instruments are developed for eye care.
bausch.comBridgewater, United States1853May 2013$8.7B
Premium access

Complete acquisition details for Bausch Health

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Bausch Health

14 dated milestones of Bausch Health across 65 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bausch Health is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $14.5M.
  4. Acquisition Acquires Bausch & Lomb.
  5. Acquisition Acquires Euvipharm.
  6. Acquisition Acquires Solta.
  7. Acquisition Acquires PreCision Dermatology.
  8. Acquisition Acquires Salix Pharmaceuticals.
  9. Acquisition Acquires Paragon Vision Sciences.
  10. Acquisition Acquires Sprout Pharmaceuticals.
  11. Acquisition Acquires Euvipharm Pharmaceutical.
  12. Acquisition Acquires Paragon AR.
  13. Funding Latest funding round, Debt – Conventional, of $500.0M.
  14. Acquisition Acquires DURECT.

Web traffic of Bausch Health

The website of Bausch Health (bauschhealth.com) receives about 32.2K visits a month and ranks #988,502 among all websites worldwide, #1,205 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    32.2K

    ▲ 18.2% vs previous month

  • Unique visitors
    13.7K

    per month

  • Global rank
    #988,502

    among all websites

  • Category rank
    #1,205

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Bausch Health. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
organon.com
100%
#267,781View details
takeda.com
100%
620.1K#93,966View details
alfasigma.com
80%
55.2K#605,770View details
datumdental.com
75%
3.1K#7,298,366View details
bausch.com
69%
175.4K#271,734View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 10 similar websites and full traffic analytics for Bausch Health

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bausch Health

Premium access

Complete news archive for Bausch Health

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bausch Health

Bausch Health was founded in 1960 and raised its 1st funding round 42 years after it was founded.

Bausch Health is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.

Joseph Papa is the CEO of Bausch Health, as recorded in our data.

Bausch Health has 20,700 employees.

Annual revenue of Bausch Health is $10.47B as on Dec 31, 2025.

Founded in 1960 and headquartered in Laval, Canada, operations focus on the pharmaceutical sector where therapeutics are developed for conditions in dermatology, gastrointestinal disorders, eye health, neurology, and other areas. Products such as the lead candidate IDP-120 for acne treatment are manufactured. In 2023, annual revenues of 8.15 billion were recorded alongside a net loss of 0.36 billion.

Bausch Health offers Gastrointestinal Products, Dermatology Products, and Vision Care Products.

Yes, Bausch Health is publicly traded on TSX under the ticker symbol BHC.

Bausch Health has made 19 acquisitions, including Aton Pharma, Bausch & Lomb, and DURECT.

Bausch Health has 1 investor. Key investors include ValueAct Capital.

Bausch Health operates through Bausch Health Companies Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available